Viewing Study NCT01985334


Ignite Creation Date: 2025-12-25 @ 2:18 AM
Ignite Modification Date: 2026-02-25 @ 6:05 AM
Study NCT ID: NCT01985334
Status: COMPLETED
Last Update Posted: 2019-03-19
First Post: 2013-11-04
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Study to Evaluate the Efficacy and Safety of Glycopyrronium or Indacaterol Maleate and Glycopyrronium Bromide Fixed-dose Combination Regarding Symptoms and Health Status in Patients With Moderate COPD Switching From Treatment With Any Standard COPD Regimen
Sponsor: Novartis Pharmaceuticals
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None COPD View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Moderate COPD, glycopyrronium bromide, indacaterol maleate and glycopyrronium bromide FDC, … View